Kiora Pharmaceuticals (KPRX) Projected to Post Earnings on Monday

Kiora Pharmaceuticals (NASDAQ:KPRX) is anticipated to announce its earnings results before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.64) per share and revenue of $0.75 million for the quarter.

Kiora Pharmaceuticals Trading Down 0.3 %

Shares of KPRX opened at $3.24 on Monday. Kiora Pharmaceuticals has a fifty-two week low of $2.91 and a fifty-two week high of $6.48. The firm has a 50-day simple moving average of $3.56 and a 200-day simple moving average of $3.51.

About Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc, a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1b clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.